My husband is participating in a first in human or Phase 1 clinical trial.  This trial is for kidney cancer and being conducted at The National Institutes of Health (NIH).  I’ll be writing about his experience as a trial patient over the next several weeks.

Clinical Trial Phase 1:

Researchers test a new drug or treatment for the first time in a small group of people (20-80) to evaluate its safety, determine a safe dosage range and identify side effects.  Learn about the different phases here.

About NIH:

NIH is considered America’s research hospital.  It’s an Agency of the US Department of Health and Human Services and is located in Bethesda, Md.  NIH has supported 153 Nobel Prize Winners.

Study related tests, procedures and medications are provided at no cost as is most travel. Admission is selective: only those patients who have a medical condition being studied by NIH who meet the specific inclusion criteria can enroll in the studies. The clinical center is the largest hospital devoted solely to clinical investigation in the world.  

Some of the Clinical Center’s successes include pioneering the cure of cancerous sold tumors with chemotherapy; the use of nitroglycerin to treat heart attacks; identifying a genetic component in schizophrenia; conducting the first successful replacement of a mitral vale to treat heart disease; and the creation of blood tests to identify both AIDS and hepatitis.

I encourage everyone to learn more about clinical trials and ask your doctor about participation.

When you participate in a clinical trial, you are joining the front line against a disease. This is where treatments are tested and medical science advanced.

It’s where researchers learn what works – clinical trials are vital to research.

WHO WE ARE →

WHAT WE DO →

OUR STORIES →

THE KIDNEY CANCER COMMUNITY →

SCIENTIFIC ADVISORS →

DONATE →

CONTACT →

Latest News

Debra Beyhan: Embracing the Ups and Downs of Life with Kidney Cancer

Debra Beyhan: Embracing the Ups and Downs of Life with Kidney Cancer

Deb Beyhan is the Patient Legislative Advocate for KidneyCAN. She was diagnosed with stage IV kidney cancer in 2016 at the age of 53. Deb lives outside of Atlanta, GA, with her husband.    For this month's Community Spotlight, we want to tell you about a member of our volunteer team, Deb Beyhan....

DISTRICT DAYS 2022 →

SPRING ADVOCACY DAYS 2022 →

JOIN OUR COMMUNITY →

RAISING AWARENESS →

BE AN ADVOCATE →

DONATE NOW →

CONTACT →

Latest News

District Days: Asking Congress to Fund Kidney Cancer Research

District Days: Asking Congress to Fund Kidney Cancer Research

On August 8-9th, KidneyCAN gathered advocates from all over the United States to ask Congress for robust funding for kidney cancer research through the NIH and CDMRP (Congressionally Directed Medical Research Programs). Read on to hear about our goals for this event and how you can help fund...

Patient Resource Center

UNDERSTANDING YOUR KIDNEY CANCER DIAGNOSIS

BUILDING YOUR CARE TEAM

TREATMENT & TRIAL OPTIONS

LIVING WELL WITH KIDNEY CANCER

CLINICAL TRIALS →

IMMUNOTHERAPY →

KCRS: KIDNEY CANCER RESEARCH SUMMIT →

RESEARCH OPPORTUNITIES →

NEWS →

Latest News

The 2022 Kidney Cancer Research Summit

The 2022 Kidney Cancer Research Summit

Dr. Laurence Albiges (Institut Gustave Roussy) presents on the microbiome at KCRS22. The microbiome has now been recognized as one of the emerging hallmarks and enabling characteristics of cancer. KidneyCAN hosted the 4th Annual Kidney Cancer Research Summit on October 6-7, 2022  live in...

SUPPORT OUR WORK →

FUNDRAISE FOR KIDNEYCAN →

DONATE →

CONTACT →

Latest News

Rock the Run for Kidney Cancer Research Funding

Rock the Run for Kidney Cancer Research Funding

KidneyCAN had the first ever Rock the Run 5k fundraiser in October 2022. This is part of the group of KCRS22 attendees who walked and ran with us at dawn before the second conference day began. KidneyCAN is proud to share the results of the first annual Rock the Run 5K fundraiser. Our Purpose...